Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review

View ORCID ProfileStefan Baral, View ORCID ProfileAmrita Rao, View ORCID ProfileJean Olivier Twahirwa Rwema, View ORCID ProfileCarrie Lyons, View ORCID ProfileMuge Cevik, Anna E. Kågesten, View ORCID ProfileDaouda Diouf, View ORCID ProfileAnnette H. Sohn, Refilwe Phaswana-Mafuya, View ORCID ProfileAdeeba Kamarulzaman, Gregorio Millett, View ORCID ProfileJulia L. Marcus, View ORCID ProfileSharmistha Mishra
doi: https://doi.org/10.1101/2021.01.07.21249419
Stefan Baral
1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefan Baral
Amrita Rao
1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amrita Rao
  • For correspondence: arao24@jhu.edu
Jean Olivier Twahirwa Rwema
1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean Olivier Twahirwa Rwema
Carrie Lyons
1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carrie Lyons
Muge Cevik
2Division of Infection and Global Health Research, School of Medicine, University of St. Andrews, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Muge Cevik
Anna E. Kågesten
3Department of Global Public Health, Karolinska Institutet, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daouda Diouf
4Enda Santé, Dakar, Senegal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daouda Diouf
Annette H. Sohn
5TREAT Asia, amfAR, the Foundation for AIDS Research, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annette H. Sohn
Refilwe Phaswana-Mafuya
6University of Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adeeba Kamarulzaman
7University of Malaya, Kuala Lumpur, Malaysia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adeeba Kamarulzaman
Gregorio Millett
8Public Policy Office, amfAR, Washington DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia L. Marcus
9Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia L. Marcus
Sharmistha Mishra
10Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sharmistha Mishra
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background COVID-19 has rapidly emerged as a global public health threat with infections recorded in nearly every country. Responses to COVID-19 have varied in intensity and breadth, but generally have included domestic and international travel limitations, closure of non-essential businesses, and repurposing of health services. While these interventions have focused on testing, treatment, and mitigation of COVID-19, there have been reports of interruptions to diagnostic, prevention, and treatment services for other public health threats. We conducted a scoping review to characterize the impact of COVID-19 on HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition.

Methods A scoping literature review was completed using searches of PubMed and preprint servers (medRxiv/bioRxiv) from January 1st to October 31st, 2020, using Medical Subject Headings (MeSH) terms related to SARS-CoV-2 or COVID-19 and HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition. Empiric studies reporting original data collection and mathematical models were included, and available data synthesized by region. Studies were excluded if they were not written in English.

Results A total of 1604 published papers and 205 preprints met inclusion criteria, including 8.2% (132/1604) of published studies and 10.2% (21/205) of preprints: 7.3% (68/931) on HIV, 7.1% (24/339) on tuberculosis, 11.6% (26/224) on malaria, 7.8% (13/166) on sexual and reproductive health, and 12.1% (16/132) on malnutrition. Thematic results were similar across competing health risks, with substantial indirect effects of the COVID-19 pandemic and response on diagnostic, prevention, and treatment services for HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition.

Discussion COVID-19 emerged in the context of existing public health threats that result in millions of deaths every year. Thus, effectively responding to COVID-19 while minimizing the negative impacts of COVID-19 necessitates innovation and integration of existing programs that are often siloed across health systems. Inequities have been a consistent driver of existing health threats; COVID-19 has worsened disparities, reinforcing the need for programs that address structural risks. Data reviewed here suggest that effective strengthening of health systems should include investment in public health with adequate funding to ensure continuity of care for emergent and existing public health threats.

Competing Interest Statement

Annette Sohn and Gregorio Millett report funding from Viiv. Julia Marcus has consulted in the past for Kaiser Permanente Northern California on a research grant from Gilead Sciences. All other authors report no competing interests.

Funding Statement

Amrita Rao is supported in part by the National Institute of Mental Health [F31MH124458]. Julia Marcus is supported in part by the National Institute of Allergy and Infectious Diseases [K01AI122853].

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We conducted a scoping literature review of published and preprint papers. No individual human subjects data was collected or accessed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Disclosures Annette Sohn and Gregorio Millett report funding from Viiv. Julia Marcus has consulted in the past for Kaiser Permanente Northern California on a research grant from Gilead Sciences. All other authors report no competing interests.

  • Funding Amrita Rao is supported in part by the National Institute of Mental Health [F31MH124458]. Julia Marcus is supported in part by the National Institute of Allergy and Infectious Diseases [K01AI122853].

  • License The Corresponding Author grants on behalf of all authors, a worldwide license to publishers and licensees for this work.

Data Availability

All articles cited in this scoping review are available and search strategies have been shared in the main document.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 08, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review
Stefan Baral, Amrita Rao, Jean Olivier Twahirwa Rwema, Carrie Lyons, Muge Cevik, Anna E. Kågesten, Daouda Diouf, Annette H. Sohn, Refilwe Phaswana-Mafuya, Adeeba Kamarulzaman, Gregorio Millett, Julia L. Marcus, Sharmistha Mishra
medRxiv 2021.01.07.21249419; doi: https://doi.org/10.1101/2021.01.07.21249419
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review
Stefan Baral, Amrita Rao, Jean Olivier Twahirwa Rwema, Carrie Lyons, Muge Cevik, Anna E. Kågesten, Daouda Diouf, Annette H. Sohn, Refilwe Phaswana-Mafuya, Adeeba Kamarulzaman, Gregorio Millett, Julia L. Marcus, Sharmistha Mishra
medRxiv 2021.01.07.21249419; doi: https://doi.org/10.1101/2021.01.07.21249419

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (455)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5294)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (760)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (702)
  • Health Policy (362)
  • Health Systems and Quality Improvement (224)
  • Hematology (100)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5934)
  • Intensive Care and Critical Care Medicine (367)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (135)
  • Obstetrics and Gynecology (146)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (138)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2035)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)